• In late June 2026, FormFactor, Inc. was removed from several Russell small-cap and value indices and added to the Russell 1000, Russell Midcap, and Russell 1000 Growth benchmarks, following its evolving classification within the US equity universe.
• This index migration, alongside a US$24,000,000 Texas IC fund grant backing expansion of its probe card production in Texas, highlights FormFactor’s shift toward a larger-cap, growth-oriented role in semiconductor testing and advanced AI hardware infrastructure.
• We’ll now examine how FormFactor’s move into the Russell 1000 Growth and Midcap indices may reshape its AI-focused investment narrative.

Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

FormFactor Investment Narrative Recap

To own FormFactor today, you need to believe that rising test complexity in AI, HBM and advanced packaging will support healthier margins over time, despite recent valuation concerns and volatile demand. The latest Russell index reclassification and US$24,000,000 Texas grant reinforce its growth profile, but do not fundamentally change the near term tug of war between AI driven probe card demand as a key catalyst and margin pressure and customer concentration as the central risks.

The Texas IC fund grant is especially relevant here, because it directly supports expansion of the new Farmers Branch probe card facility that underpins the AI and HBM opportunity. While this added capacity could eventually help lower unit costs and support FormFactor’s long term gross margin ambitions, investors still face a period where higher operating expenses and ramp up costs may weigh on cash flow and profitability before the benefits fully show up.

Yet beneath this growth story, investors should still be aware of how customer concentration and product mix could...

FormFactor's narrative projects $1.3 billion revenue and $365.1 million earnings by 2029. This requires 16.3% yearly revenue growth and about a $296.8 million earnings increase from $68.3 million today.

Uncover how FormFactor's forecasts yield a $144.67 fair value, a 36% upside to its current price.

Exploring Other Perspectives

Against this backdrop, the most bearish analysts were already penciling in 11.4% annual revenue growth and earnings of about US$187.6 million by 2029, yet still saw risk that rising capital spending and margin pressure could justify a much lower valuation than today. Their view sits in sharp contrast to more optimistic expectations for AI driven test demand and highlights how your own take on the Texas expansion and index move could shift as these narratives are updated.

Explore 5 other fair value estimates on FormFactor - why the stock might be worth less than half the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your FormFactor research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free FormFactor research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate FormFactor's overall financial health at a glance.

Interested In Other Possibilities?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.
• The future of work is here. Discover the 29 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Outshine the giants: these 15 early-stage AI stocks could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.